The TP53 mutations were found in three (21.4%) of 14 luminal A tumors, four (36.4%) of 11 luminal B tumors, two (66.7%) of three triple-negative and one (100%) of one Her2-positive tumor. This evidence concerns the gene ERBB2 and neoplasm.